Vaccinia virus is one of the most widely applied expression systems for use in eukaryotes in molecular biology. Expression of heterologous genes in the vaccinia virus system, however, requires integration of the foreign DNA into the vaccinia virus genome by means of homologous recombination or by direct molecular cloning. In both cases, plasmid vector constructs are required that contain the gene of interest and, usually, a marker gene, both of which are controlled by suitable promoter sequences. In order to simplify the construction of recombinants and to eliminate the need for a marker gene we have developed a modified vaccinia virus genome that allows the direct targeted insertion of DNA fragments downstream of a strong vaccinia virus promoter without any further cloning steps. The gene of interest is amplified by PCR using oligonucleotide primers that provide an SfiI site at the 5′ end and an RsrII site at the 3′ end of the PCR product. Following digestion with these restriction enzymes, the PCR product is operationally linked to a synthetic early/late promoter within the viral genomic DNA via the unique SfiI/RsrII sites of the modified vaccinia virus genome. Using this approach, intermediate plasmid constructs and bacterial hosts are not required and time consuming screening steps can be omitted, because 90% of the virus progeny carry the foreign DNA.
BerishS. A.,
ChenY.-C.,
MietznerT. A.,
MorseS. A.1992; Expression of a functional neisserial fbp gene in Escherichia coli
. Molecular Microbiology 6:2607–2615
DavisonA. J.,
MossB.1990; New vaccinia virus recombination plasmids incorporating a synthetic late promoter for high level expression of foreign proteins. Nucleic Acids Research 14:4285–4286
Elroy-SteinO.,
FuerstT. R.,
MossB.1989; Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5′ sequence improves the performance of the vaccinia virus/ bacteriophage T7 hybrid expression system. Proceedings of the National Academy of Sciences, USA 86:6126–6130
ErnstW. J.,
GrabherrM. R.,
KatingerH. W. D.1994; Direct cloning into the Autographa californica nuclear polyhedrosis virus for generation of recombinant baculoviruses. Nucleic Acids Research 22:2855–2856
FuerstT. R.,
EarlP. L.,
MossB.1987; Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes. Molecular and Cellular Biology 7:2538–2544
GibbsC. P.,
CrossG. A. M.1988; Cloning and transcriptional analysis of a variant surface glycoprotein gene expression site in Trypanosoma brucei
. Molecular and Biochemical Parasitology 28:197–206
KurachiK.,
DavieE. W.1982; Isolation and characterization of a cDNA coding for human factor IX. Proceedings of the National Academy of Sciences, USA 79:6461–6464
MackettM.,
SmithG. L.,
MossB.1982; Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proceedings of the National Academy of Sciences, USA 79:7415–7419
MayrA.,
MalickiK.1966; Attenuierung von virulentem Hühnerpockenvirus in Zellkulturen und Eigenschaften des atten- uierten Virus. Zentralblatt fur Veterinärmedizin (Reihe B) 13:1–12
MerchlinskyM.,
MossB.1992; Introduction of foreign DNA into the vaccinia virus genome by in vitro ligation: recombination- independent selectable cloning vectors. Virology 190:522–526
MulliganR.,
BergP.1981; Selection for animal cells that express the E. coli gene coding for xanthine-guanine phosphoribosyl transferase. Proceedings of the National Academy of Sciences, USA 78:2072–2076
PanicaliD.,
PaolettiE.1982; Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus. Proceedings of the National Academy of Sciences, USA 79:4927–4931
PatelD. D.,
RayC. A.,
DruckerR. P.,
PickupD. J.1988; A poxvirus derived vector that directs high levels of expression of cloned genes in mammalian cells. Proceedings of the National Academy of Sciences, USA 85:9431–9435
PfleidererM.,
FalknerF. G.,
DornerF.1995; Requirements for optimal expression of secreted and non-secreted recombinant proteins in vaccinia virus systems. Protein Expression and Purification 6:559–569
RixonF. J.,
McLauchlanJ.1990; Insertion of DNA sequences at a unique restriction enzyme site engineered for vector purposes into the genome of herpes simplex virus type 1. Journal of General Virology 71:2931–2939
ScheiflingerF.,
DornerF.,
FalknerF. G.1992; Construction of chimeric vaccinia virus by molecular cloning and packaging. Proceedings of the National Academy of Sciences, USA 89:9977–9981
TurnerC. T.,
MoyerR. W.1992; A PCR based method for manipulation of the vaccinia virus genome that eliminates the need for cloning. BioTechniques 13:764–771
ZhouJ.,
CrawfordL.,
SunX.-Y.,
FrazerI. H.1991; The hygromycin-resistance-encoding gene as a selection marker for vaccinia virus recombinants. Gene 107:307–312